| Dr Alexandra Marcotty, MD | |
|
5555 E Arapahoe Rd, Centennial, CO 80122-2312 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Alexandra Marcotty |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 5555 E Arapahoe Rd, Centennial, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336432996 | NPI | - | NPPES |
| 028991 | Other | CO | KAISER COMMERCIAL NUMBER |
| 49203533 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 55177 (Colorado) | Primary |
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
"The World Health Organization (WHO) on Friday said that Nigeria, Cameroon and Chad, who are in the 'meningitis belt' stretching across Africa, will this month introduce a new vaccine designed to eliminate a particular strain of the often deadly disease," Afrique en ligne reports.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D® 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. Teva's product is an alternative to the brand product, which had annual sales of approximately $293 million in the United States for the twelve months that ended June 30, 2009, based on IMS sales data.
Many of us wish that Obamacare were a simpler system, one that directly provided health insurance. Political reality, unfortunately, ensured that many people will receive coverage from private insurers, selling policies -; often with subsidies -; on the "exchanges". And naturally enough, the Obama administration is teaming up with the insurers and other parts of the health industry to help inform Americans of the benefits to which they will be legally entitled, starting Jan. 1 (Paul Krugman, 6/12).
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Marcotty, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-3382 | Dr Alexandra Marcotty, MD 5555 E Arapahoe Rd, Centennial, CO 80122-2312 Ph: (303) 338-4545 |
News Archive
"The World Health Organization (WHO) on Friday said that Nigeria, Cameroon and Chad, who are in the 'meningitis belt' stretching across Africa, will this month introduce a new vaccine designed to eliminate a particular strain of the often deadly disease," Afrique en ligne reports.
The smell of cut grass, freshly baked bread, childhood memories, lost loved ones. What happens when it's all gone?
Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D® 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. Teva's product is an alternative to the brand product, which had annual sales of approximately $293 million in the United States for the twelve months that ended June 30, 2009, based on IMS sales data.
Many of us wish that Obamacare were a simpler system, one that directly provided health insurance. Political reality, unfortunately, ensured that many people will receive coverage from private insurers, selling policies -; often with subsidies -; on the "exchanges". And naturally enough, the Obama administration is teaming up with the insurers and other parts of the health industry to help inform Americans of the benefits to which they will be legally entitled, starting Jan. 1 (Paul Krugman, 6/12).
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
› Verified 5 days ago
Barbara J Thompson, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-850-2074 | |
Dr. Myda Thi Luu, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 | |
Dr. Simon D Payne, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 | |
Dr. Cynthia J Celnik, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 | |
Dr. Jill J Ingenito, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 | |
Dr. Zachary Thomas Ripp, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 |